Mergers & Acquisitions

  • March 05, 2025

    Cleanova, Micronics Combine To Create $1.3B Business

    Private equity-owned clean technology maker Cleanova on Wednesday announced plans to buy fellow private equity-owned clean technology manufacturer Micronics Engineered Filtration Group to create a company with an enterprise value of $1.3 billion, in a deal built by three law firms.

  • March 05, 2025

    UK Clears $35B Synopsys, Ansys Merger

    The Competition and Markets Authority said Wednesday it has cleared Synopsys' planned $35 billion acquisition of fellow U.S. software company Ansys under certain divestiture and monitoring conditions.

  • March 05, 2025

    Longtime DOJ Antitrust Litigator Joins Fried Frank In DC

    Fried Frank Harris Shriver & Jacobson LLP announced that a Cooley LLP attorney who previously spent more than 15 years in the U.S. Department of Justice's Antitrust Division has joined the firm's Washington, D.C., office as a partner.

  • March 05, 2025

    Del. Corporate Law Bill Poses 'Grave Risk,' Plaintiffs' Firms Say

    Five of Delaware's most active corporate litigation plaintiffs' firms have branded pending legislation aimed at curbing stockholder suits as a "dangerous and radical" measure that attacks the state's courts and will put Delaware's nationally known incorporation franchise "at grave risk."

  • March 05, 2025

    DOJ Fights Bid To Pause Piece Of Amedisys Merger Case

    The U.S. Department of Justice is opposing a bid from Amedisys to pause allegations that it shirked its merger filing requirements until after a trial on UnitedHealth's acquisition of the home health and hospice company.

  • March 05, 2025

    KKR, Walmart Selling Japanese Supermarket Chain For $2.5B

    KKR and Walmart have agreed to sell their 85% and 15% respective stakes in Tokyo-based supermarket chain Seiyu to Japan's Trial Holdings Inc. for a total of 380 billion yen ($2.55 billion), the companies said Wednesday. 

  • March 05, 2025

    3 Firms Build Jazz Pharmaceuticals' $935M Chimerix Buy

    Jazz Pharmaceuticals on Wednesday revealed plans to acquire biopharmaceutical company Chimerix in a $935 million deal built by three law firms that will further diversify Jazz's oncology portfolio.

  • March 05, 2025

    UK Drops Probe Into Microsoft's OpenAI Partnership

    Britain's antitrust authority said Wednesday that it has dropped its probe into Microsoft's investment into ChatGPT developer OpenAI after finding it does not have the jurisdiction to look into their complex partnership.

  • March 05, 2025

    Danish Retailer Salling To Buy ICA's Baltic Biz For €1.3B

    Danish retailer Salling Group AS said Wednesday it will buy Baltic supermarket chain Rimi from its Swedish rival ICA Gruppen AB for €1.3 billion ($1.39 billion), as the Danish retailer eyes growing to become the region's second-largest player.

  • March 05, 2025

    Breedon Buys US Building Products Biz Lionmark For $238M

    Breedon Group PLC announced on Wednesday the acquisition of U.S.-based Lionmark Construction Companies LLC for $238 million as the U.K. construction materials group looks to diversify its business and continue its expansion in the U.S. market.

  • March 05, 2025

    UK Gold Producer To Buy Processing Plant For $9.7M

    The U.K.-headquartered gold producer Metals Exploration PLC said Wednesday it has agreed to buy an ore processing plant in Alaska and related assets for $9.7 million from Almaden Minerals Ltd. to fast-track the construction of its La India mining project in Nicaragua.

  • March 05, 2025

    Royal Mail's £3.6B Sale Awaiting Romanian Clearance

    The proposed £3.6 billion ($4.6 billion) acquisition of the parent company of Royal Mail by a conglomerate controlled by a Czech billionaire is awaiting clearance in Romania, the companies said Wednesday.

  • March 04, 2025

    Avalara Investor Asks 9th Circ. To Revive $8B PE Buyout Suit

    An Avalara shareholder urged the Ninth Circuit on Tuesday to revive a proposed securities class action alleging the tax software company duped investors into approving a "deficient" $8.4 billion private equity buyout, arguing the trial court erred in finding Avalara's statements tied to "numerically specific metrics" weren't false or misleading.

  • March 04, 2025

    Musk Fails To Block OpenAI From Turning Into For-Profit Entity

    A California federal judge on Tuesday denied Elon Musk's bid to preliminarily bar OpenAI Inc. from converting into a for-profit entity, saying that a threshold question of whether Musk's over $44 million in donations created a charitable trust was a "toss-up."

  • March 04, 2025

    Agencies Have 'Ultimate' Authority Over Firings, OPM Says

    The Office of Personnel Management on Tuesday issued a revised version of its January memo directing agency heads to identify all probationary employees, adding a disclaimer that OPM "is not directing agencies to take any specific performance-based actions" and that agencies "have ultimate decision-making authority."

  • March 04, 2025

    NC Judge Wants 1st Look At Info In Hospital Sale Suit

    A North Carolina judge has ruled that she needs to be the first one to review potentially privileged information sought in Attorney General Jeff Jackson's suit alleging that a hospital sale agreement was breached, reasoning that it's too early to determine if they're public record or shielded attorney-client communications.

  • March 04, 2025

    Linklaters Adds Second Ex-Mayer Brown M&A Partner In NY

    Linklaters LLP has announced the hiring of a former Mayer Brown partner for its mergers and acquisitions practice in New York, a little over three months after bringing aboard the former co-leader of Mayer Brown's infrastructure M&A practice.

  • March 04, 2025

    Day Pitney Hires Founder Of Legal Intelligence Company

    Day Pitney LLP has hired the founder of a legal intelligence company and former co-head of the New York corporate and transactions group at McDermott Will & Emery LLP, the firm announced this week.

  • March 04, 2025

    3 Firms Build Instinct Brothers' $242M SPAC Merger

    Japanese regenerative medicine and stem cell technology company Instinct Brothers Co. Ltd. on Tuesday unveiled plans to go public through a merger with special purpose acquisition company Relativity Acquisition Corp. in a $242 million deal built by three law firms.

  • March 04, 2025

    Paul Hastings Real Assets Pro Jumps To Proskauer In LA

    Proskauer Rose LLP is expanding its California team, bringing in a Paul Hastings LLP real assets ace as a partner in its Los Angeles office.

  • March 04, 2025

    Honeywell Paying $2.2B For Sundyne Amid $25B Deployment

    Honeywell said Tuesday it has agreed to acquire pump and gas compressor maker Sundyne from private equity firm Warburg Pincus for $2.16 billion, part of a restructuring plan that calls for the industrial conglomerate to deploy at least $25 billion by the end of 2025. 

  • March 04, 2025

    Former Fried Frank Antitrust Partner Joins Davis Polk

    Davis Polk & Wardwell LLP announced it has hired a former Fried Frank Harris Shriver & Jacobson LLP antitrust attorney as a partner in its antitrust and competition practice in New York. 

  • March 04, 2025

    Verdane Ends £315M Offer Talks For Team Internet

    Swedish investment manager Verdane on Tuesday said it has backed out of talks to make a £315 million ($401 million) offer for British software company Team Internet Group PLC.

  • March 04, 2025

    Abu Dhabi, Austria Groups Agree To $60B Plastics Biz Merger

    The Abu Dhabi National Oil Co. and OMV AG of Austria said Tuesday that they will merge their plastics businesses to create a $60 billion global heavyweight, concluding lengthy talks about the deal.

  • March 03, 2025

    ITG Owes Reynolds Tobacco $251M For Settlement Payments

    ITG Brands LLC owes R.J. Reynolds Tobacco Co. roughly $251 million for payments R.J. Reynolds made to the state of Florida under a settlement reached before ITG acquired cigarette brands from it, according to an order issued by a Delaware vice chancellor Monday.

Expert Analysis

  • Predictions For Trump Antitrust Enforcement Of Life Sciences

    Author Photo

    Key life sciences antitrust issues of the past two administrations may indicate the direction of enforcement during President-elect Donald Trump's second term, including in areas such as drug prices, killer acquisitions and merger remedies, say attorneys at Ropes & Gray.

  • Firms Still Have The Edge In Lateral Hiring, But Buyer Beware

    Author Photo

    Partner mobility data suggests that the third quarter of this year continued to be a buyer’s market, with the average candidate demanding less compensation for a larger book of business — but moving into the fourth quarter, firms should slow down their hiring process to minimize risks, say officers at Decipher Investigative Intelligence.

  • Preparing For The New Restrictions On Investment Into China

    Author Photo

    In light of a new regulatory program governing U.S. investments in China-related technology companies of national security concern, investors should keep several considerations in mind, including the rules' effect on existing and new investments, compliance hurdles, and penalties for noncompliance ahead of the rules' January implementation, say attorneys at Gunderson Dettmer.

  • Lights, Camera, Real Estate: Preparing For Film Facility M&A

    Author Photo

    As the entertainment industry struggles to recover from multiple strikes and a decline in production, certain aspects of selling or acquiring production facilities may become important to consider, as these assets are valued very differently from typical commercial real estate properties, say attorneys at Olshan Frome.

  • Think Like A Lawyer: 1 Type Of Case Complexity Stands Out

    Author Photo

    In contrast to some cases that appear complex due to voluminous evidence or esoteric subject matter, a different kind of complexity involves tangled legal and factual questions, each with a range of possible outcomes, which require a “sliding scale” approach instead of syllogistic reasoning, says Luke Andrews at Poole Huffman.

  • Back To The Future? Antitrust Enforcement Under Trump 2.0

    Author Photo

    While the transition to the second Trump administration's antitrust policy should be accompanied by less uncertainty, we're unlikely to get a full sense of the true focus and tenor of competition enforcement under Trump 2.0 before late next year, say attorneys at Simpson Thacher.

  • Think Like A Lawyer: Note 3 Simple Types Of Legal Complexity

    Author Photo

    Cases can appear complex for several reasons — due to the number of issues, the volume of factual and evidentiary sources, and the sophistication of those sources — but the same basic technique can help lawyers tame their arguments into a simple and persuasive message, says Luke Andrews at Poole Huffman.

  • Antitrust in Retail: Handbag Ruling Won't Go Out Of Fashion

    Author Photo

    Although a New York federal court’s recent decision to enjoin a proposed $8.5 billion merger between the owners of Michael Kors and Coach applied noncontroversial antitrust interpretations, several notable aspects of the opinion stand out as likely candidates for further discussion in future merger litigation, say attorneys at Holland & Knight.

  • Series

    Gardening Makes Me A Better Lawyer

    Author Photo

    Beyond its practical and therapeutic benefits, gardening has bolstered important attributes that also apply to my litigation practice, including persistence, patience, grit and authenticity, says Christopher Viceconte at Gibbons.

  • Takeaways From DOJ's Intervention On Pricing Algorithm Use

    Author Photo

    A recent U.S. Justice Department amicus brief arguing that a Nevada federal judge wrongly focused on the nonbinding aspect of software company Cendyn Group's pricing algorithm underscores the growing challenge of determining when, if ever, pricing algorithms are legal, say attorneys at Rule Garza.

  • Equitable Mootness Insights From Greenlit Ch. 11 Plan Appeal

    Author Photo

    A Texas federal court recently allowed a challenge to ConvergeOne's Chapter 11 bankruptcy plan to proceed because it wouldn't disrupt the IT company's confirmed plan or harm creditors, reinforcing the importance of judicial restraint in applying equitable mootness where limited relief is possible, say attorneys at Parkins & Rubio.

  • Litigation Inspiration: Reframing Document Review

    Author Photo

    For attorneys — new ones especially — there is much fulfillment to find in document review by reflecting on how important, interesting and pleasant it can be, says Bennett Rawicki at Hilgers Graben.

  • Expect More State Scrutiny Of PE In Healthcare M&A

    Author Photo

    While a California bill that called for increased antitrust scrutiny of many healthcare private equity transactions was recently vetoed by the governor, state legislatures are likely to continue introducing similar laws, particularly if the Trump administration eases federal enforcement, say attorneys at Morgan Lewis.

  • 3 Changes Community Banks Should Expect Under Trump

    Author Photo

    A second Trump administration promises a sea change for regional and community banks, including shifts in the regulatory environment, Community Reinvestment Act rules and the M&A landscape, say attorneys at Manatt.

  • How CFIUS' Updated Framework Affects Global Investors

    Author Photo

    The recent change to the monitoring and enforcement regulations governing the Committee on Foreign Investment in the United States will broaden administrative practices around nonnotified transaction investigations, increase the scope of information demands from the committee and accelerate its ability to impose mitigation on parties, say attorneys at Simpson Thacher.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Mergers & Acquisitions archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!